Team:Toulouse/Safety

From 2014.igem.org

(Difference between revisions)
Line 544: Line 544:
<p class="title3">How to reduce these Future risks?</p>
<p class="title3">How to reduce these Future risks?</p>
<p class="texte">We have thought about several ways to minimize risks: <br>
<p class="texte">We have thought about several ways to minimize risks: <br>
-
- we choose an auxotrophic strain of B. subtilis. The auxotrophy is for the glutamic acid, which is very present in plant's sap.<br>
+
- we choose an auxotrophic strain of <I>B. subtilis</I>. The auxotrophy is for the glutamic acid, which is very present in plant's sap.<br>
-
- we choose a non-spore-forming strain of B. subtilis. The sporulation is the endophytic bacteria mechanism used to survive through winter. Thus, our bacterial system will be time limited.<br>
+
- we choose a non-spore-forming strain of<I>B. subtilis</I>. The sporulation is the endophyte bacteria mechanism used to survive through winter. Thus, our bacterial system will be time limited.<br>
- we want to use a toxin/antitoxin system to avoid gene transfer between our optimized bacterium and another wild-type bacteria.</p>
- we want to use a toxin/antitoxin system to avoid gene transfer between our optimized bacterium and another wild-type bacteria.</p>

Revision as of 13:44, 16 October 2014